Why Shares of Myriad Genetics Dropped 24% This Week
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
What happened
Shares of Myriad Genetics (NASDAQ: MYGN), a genetic-testing and precision-medicine biotech company, were down more than 24% this week as of Thursday, according to data from S&P Global Intelligence. The stock closed last week at $20.86, then opened on Monday at $
Shares of Myriad Genetics (NASDAQ: MYGN), a genetic-testing and precision-medicine biotech company, were down more than 24% this week as of Thursday, according to data from S&P Global Intelligence. The stock closed last week at $20.86, then opened on Monday at $
:max_bytes(150000):strip_icc():format(jpeg)/modern-analyst-1316900_1920-f70c674fb760412fa184a505a51c5c2d.jpg "Common Interview Questions for Credit Risk Analysts")
:max_bytes(150000):strip_icc():format(jpeg)/SECForm425-41087544bb054a868ccbeb13482beb63.jpg "What Does a Chief Financial Officer (CFO) Do?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2159746556-2e3b77ab7fc54f1b97c114d57974e4f1.jpg "What Happens to Your Money When Your Fintech Company Goes Bust?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-119717054-dc96ff6f97be43ca89b9d19f53318a70-a8d2635c71d54da794bbfdc95d522e44.jpg "<div>Yes, You Can Retire on a Cruise Ship. Here's What It Costs</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-469310035-6b91d5b65b7449c5882b4144acd14206.jpg "Correlation Coefficients: Positive, Negative, and Zero")